References
- 1. van Dijk K, van der Bom JG, Fischer K, Grobbee DE, van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost. 2004 Aug;92(2):305-10.
- 2. Franchini M, Lippi G. Factor V Leiden and hemophilia. Thromb Res. 2010 Feb;125(2):119-23. DOI: 10.1016/j. thromres.2009.11.003
- 3. Sanna V, Zarrilli F, Nardiello P, D’Argenio V, Rocino A, Coppola A, et al. Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. Haemophilia. 2008 Jul;14(4):796-803. DOI: 10.1111/j.1365-2516.2008.01705.x
- 4. Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association! Haemophilia. 2004 Jul;10(4):319-26. DOI: 10.1111/j.1365-2516.2004.00906.x
- 5. Kurnik K, Kreuz W, Horneff S, Düring C, Schobess R, Bidlingmaier C, et al. Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter study. Haematologica. 2007 Jul;92(7):982-5. DOI: 10.3324/haematol.11161
- 6. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V - associated with resistance to activated protein C. Nature. 1994 May 5; 369(6475):64-7. DOI: 10.1038/369064a0
- 7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3`-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996 Nov 15;88(10):3698-703.
- 8. Födinger M, Hörl WH, Sunder-Plassmann G. Molecular biology of 5, 10-methylenetetrahydrofolate reductase. J Nephrol. 2000 Jan-Feb;13(1):20-33.
- 9. Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common Methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998 May; 62(5):1258-60. DOI: 10.1086/301836
- 10. Abeer M, Hesham A. Genetic polymorphisms of Plasminogen Activator Inhibitor-1, vascular endothelial growth factor and angiotensin converting enzyme among pre-eclamptic women. Egypt J Med Lab Sci. 2010 Mar; 19(1):39-44.
- 11. Nordt TK, Lohrmann J, Bode C. Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. Thromb Res. 2001 Sep;103 Suppl 1:S1-5.DOI: 10.1016/S0049-3848(01)00292-4
- 12. Falk G, Almquist A, Nordenhem A, Svensson H, Wiman B. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis. 1995 May;9(3):170-4. DOI: 10.1016/S0268-9499(95)80007-7
- 13. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111-3. DOI: 10.1038/ng0595-111
- 14. Xenophontos SL, Hadjivassiliou M, Ayrton N, Karagrigoriou A, Pantzaris M, Nicolaides AN, et al. Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population. Int Angiol. 2002 Dec;21(4):322-9.
- 15. Saour JN, Shoukri MM, Mammo LA. The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results. Saudi Med J. 2009 Oct; 30(10):1286-90.
- 16. Hussein AS. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T. J Thromb Thrombolysis. 2012 Oct;34(3):383-7. DOI: 10.1007/s11239-012-0731-9
- 17. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995 Oct;346(8983):1133-4. DOI: 10.1016/S0140-6736(95)91803-5
- 18. Lucotte G, Mercier G. Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis. 2001 Mar- Apr;27(2):362-7. DOI: 10.1006/bcmd.2001.0388
- 19. Roosendaal FR, Doggen C, Zivelin A, Arruda V, Aiach M. Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost. 1998 Apr;79(4):706-8.
- 20. Alfirevic Z, Simundic A, Nikolac N, Sobocan N, Alfirevic I, Stefanovic M, et al. Frequency of factor II G20210A, factor V Leiden, MTHFR C677T and PAI-1 5G/4G polymorphism in patients with venous thromboembolism: Croatian case control study. Biochemia Medica. 2010 Mar;20(2):229-35. DOI: 10.11613/ BM.2010.028
- 21. Kvasnička T, Hájková J, Bobčíková P, Cverhová V, Malíková I, Ulrych J, et al. The Frequencies of Six Important Thrombophilic Mutations in a Population of the Czech Republic. Physiol Res. 2014 Jan;63(2):245-53.
- 22. Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-Methylenetetrahydrofolate reductase. Am J Hum Genet. 1998 Sep;63(3):917-20. DOI: 10.1086/302015
- 23. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of Prothrombin G20210A, Factor V G1691A (Leiden), and MethylenetetrahydrofolateReductase (MTHFR) C677T in Seven Different Populations Determined by Multiplex Allele-specific PCR. Thromb Haemost. 1999 May;81(5):733-8.
- 24. Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, et al. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost. 2001 Feb;85(2):218-20.
- 25. Nowak-Göttl U, Escuriola C, Kurnik K, Schobess R, Horneff S, Kosch A, et al. Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations? Hämostaseologie. 2003 Feb;23(1):36-40.
- 26. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S et al. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr. 1999 Sep;129(9):1656-61.
- 27. Bavikatty NR, Killeen AA, Akel N, Normolle D, Schmaier AH. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population. Am J Clin Pathol. 2000 Aug; 114(2):272-5. DOI: 10.1309/LQKG-F0D4-C6FFFNEH